z-logo
Premium
Response to FDA Commissioner's statement on Dsuvia approval
Author(s) -
Bernstein Michael H.,
Beaudoin Francesca L.,
Magill Molly
Publication year - 2019
Publication title -
addiction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.424
H-Index - 193
eISSN - 1360-0443
pISSN - 0965-2140
DOI - 10.1111/add.14539
Subject(s) - medicine , sufentanil , context (archaeology) , opioid , fentanyl , naltrexone , randomized controlled trial , morphine , anesthesia , surgery , paleontology , receptor , biology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom